|
Title
|
Published
|
Price
|
By
GlobalData
Autoimmune Technologies, LLC (Autoimmune) is a biomedical company. The company develops medical diagnostic tests, explores disease mechanisms and investigates therapies for autoimmune diseases and disorders. It develops anti-viral drugs that are desi
|
May
2013
|
$
750
|
By
Global Markets Direct
Global Markets Direct’s, 'Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H2 2011', provides an overview of the Acquired (Autoimmune) Hemolytic Anemia therapeutic pipeline. This report provides information on the therapeutic development for
|
November
2011
|
$
500
|
By
GlobalData
Autoimmune Technologies, LLC (Autoimmune) is a privately held biomedical company in the US. It develops medical diagnostic tests, explores disease mechanisms, and investigates therapies for autoimmune diseases and other disorders. Besides, the compan
|
November
2011
|
$
750
|
By
Global Markets Direct
Global Markets Direct’s, '', provides an overview of the Acquired (Autoi...
|
May
2011
|
$
500
|
By
Life Science Analytics
Report includes a business , tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of d...
|
March
2011
|
$
350
|
By
Life Science Analytics
Life Science Analytics', contains detailed information on the autoimmune diseases drug pipel...
|
March
2011
|
$
1495
|
By
ICON Group International, Inc.
This econometric study covers the world outlook for autoimmune disease therapeutics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ...
|
January
2011
|
$
795
|
By
ICON Group International, Inc.
This econometric study covers the latent demand outlook for autoimmune disease therapeutics across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalitie...
|
January
2011
|
$
495
|
By
GlobalData
AutoImmune Inc. is a biopharmaceutical company focused on developing drugs to treat autoimmune and cell mediated inflammatory diseases. The company's products are based on the principles of mucosal tolerance. It sells the products through i...
|
December
2010
|
$
125
|
By
Life Science Analytics
report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on...
|
July
2010
|
$
750
|
By
Life Science Analytics
Report Description:Life Science Analytics', Rheumatoid Arthritis Therapy Area Pipeline Report contains detailed information on the rheumatoid arthritis drug pipeline. This report provides insight into the pipeline statu...
|
January
2010
|
$
1499
|
By
Life Science Analytics
Report Description:Life Science Analytics', Allergy Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of allergy drugs by comp...
|
January
2010
|
$
1495
|
By
Life Science Analytics
Report Description:Life Science Analytics', Arthritis Therapy Area Pipeline Report contains detailed information on the arthritis drug pipeline. This report provides insight into the pipeline status of arthritis drugs b...
|
January
2010
|
$
1496
|
By
Life Science Analytics
Report Description:Life Science Analytics', Autoimmune Diseases Therapy Area Pipeline Report contains detailed information on the autoimmune diseases drug pipeline. This report provides insight into the pipeline status ...
|
January
2010
|
$
1497
|
By
Life Science Analytics
Report Description:Life Science Analytics', Inflammation Therapy Area Pipeline Report contains detailed information on the inflammation drug pipeline. This report provides insight into the pipeline status of inflammatio...
|
January
2010
|
$
1498
|
By
Life Science Analytics
includes a business , tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indica...
|
January
2010
|
$
350
|
By
Life Science Analytics
Pipeline Report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.
|
January
2010
|
$
750
|
By
Life Science Analytics
is a private Company Report that provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.
|
January
2010
|
$
750
|